000 01005nam a22002774a 4500
005 20250914140321.0
008 050520s2004 nyua b 001 0 eng
020 _a0306480409
_cRM614.25
039 9 _a200509121615
_bzainol
_y05-20-2005
_zfida
060 _aQV38
090 _aQV38.G312c 2004
100 1 _aGeigert, J.
_q(John),
_d1948-
245 1 4 _aThe challenge of CMC regulatory compliance for biopharmaceuticals /
_cJohn Geigert
260 _aNew York :
_bKluwer Academic/Plenum Publishers,
_c2004
300 _axxiii, 350 p. :
_bill. ;
_c25 cm.
504 _aReferences : p. 331-346
650 2 _aBiopharmaceutics
_xstandards
_zUnited States
650 2 _aGuideline Adherence
_xlegislation & jurisprudence
_zUnited States
650 2 _aQuality control
_zUnited States
907 _a.b13528579
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQV38.G312c 2004
914 _avtls003305336
991 _aJabatan Dietetik
998 _ad
_b2005-07-05
_cm
_da
_feng
_gnyu
_y0
_z.b13528579
999 _c352047
_d352047